ProNAi Therapeutics, which is developing cancer therapies based on DNA interference, raised the proposed deal size for its upcoming IPO on Wednesday. The Vancouver, Canada-based company now plans to raise $138 million by offering 8.1 million shares at a...read more
ProNAi Therapeutics, which is developing cancer therapies based on DNA interference, announced terms for its IPO on Monday.
The Vancouver, Canada-based company plans to raise $101 million by offering 6.7 million shares at a price range of $14 to $16. At the...read more
ProNAi Therapeutics, which is developing cancer therapies based on DNA interference, filed on Friday with the SEC to raise up to $86 million in an initial public offering.
The Vancouver, Canada-based company, which was founded in 2003, plans to list on the...read more
As the NASDAQ experienced its biggest one-day drop since late 2011 amid a continued tech sell-off, the biggest losers have been companies that saw spectacular first-day trading. The market's downturn is a response to some speculative buying of these as-of-yet...read more
More capital for Canadian cancer cures: ProNAi Therapeutics increases proposed IPO deal size by 37%
ProNAi Therapeutics, which is developing cancer therapies based on DNA interference, raised the proposed deal size for its upcoming IPO on Wednesday. The Vancouver, Canada-based company now plans to raise $138 million by offering 8.1 million shares at a...read more
Canadian cancer biotech ProNAi Therapeutics sets terms for $101 million IPO
ProNAi Therapeutics, which is developing cancer therapies based on DNA interference, announced terms for its IPO on Monday. The Vancouver, Canada-based company plans to raise $101 million by offering 6.7 million shares at a price range of $14 to $16. At the...read more
Something good out of Canada: Cancer biotech ProNAi Therapeutics files for an $86 million IPO
ProNAi Therapeutics, which is developing cancer therapies based on DNA interference, filed on Friday with the SEC to raise up to $86 million in an initial public offering. The Vancouver, Canada-based company, which was founded in 2003, plans to list on the...read more
The harder they fall: high-popping IPOs hammered in aftermarket trading
As the NASDAQ experienced its biggest one-day drop since late 2011 amid a continued tech sell-off, the biggest losers have been companies that saw spectacular first-day trading. The market's downturn is a response to some speculative buying of these as-of-yet...read more